Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic. As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from around the world, including not only what has been completed, but also what is planned for future research and trials. Cardiology researchers, basic science clinicians, fellows, residents, students,…mehr
Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic. As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from around the world, including not only what has been completed, but also what is planned for future research and trials. Cardiology researchers, basic science clinicians, fellows, residents, students, and industry professionals will find this book an invaluable resource for further study on the topic.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Introduction and Overview of Stem Cells 2. Mechanistic Insights from Pathologic Perspective 3. Large Animal Models to Study Stem Cell Therapy 4. Evolution of understanding of the mechanisms of repair 5. Impact of Age on Stem Cell Function 6. Bone Marrow Mononuclear Cells 7. Chronic Limb Ischemia 8. Chronic/Refractory Angina 9. Acute Myocardial Infarction A. European Experience B. US Experience 10. Chronic Ischemic Heart Failure 11. Adipose Tissue 12. Overview of MSCs 13. Allogeneic vs Autologous Source: Comparative Effects 14. Use of MSCs for AMI 15. Combined Cell Strategies 16. Heart Failure 17. C-Kit+ cells 18. Cardiospheres 19. Umbilical Cord, Placenta, Endometrium 20. Genetic Engineering of Fibroblasts to Cardiomyocytes 21. Transformation to inducible Pleuripotent Stem Cells 22. Transformation to MAPC's 23. Transcoronary and Endocardial 24. Retrograde and Epicardial 25. Epicardial Patch 26. Matrix Scaffolds 27. Matrix plus cells 28. Biomaterial: Alginate 29. Organogenesis 30. Pre-clinical Identification of target genes 31. SERCA-2a gene for recovery of inotropic function 32. SDF-1 Gene for Heart Failure Non-Inotropic Mechanisms 33. Gene Therapy for Angiogenesis: Chronic Limb Ischemia 34. Stem Cells Target Gene Transfected Stem Cells 35. CCTRN: Past, Present, and Vision for the Future 36. Signature of Responders-lessons from Bio-Repository 37. Adjunctive therapy with LVADs for Recovery 38. Trials in Non-Ischemic Heart Failure 39. Enhancing Stem Cell Homing for Tissue Repair 40. Stroke: Pre-Clinical and Clinical Trial Data
1. Introduction and Overview of Stem Cells 2. Mechanistic Insights from Pathologic Perspective 3. Large Animal Models to Study Stem Cell Therapy 4. Evolution of understanding of the mechanisms of repair 5. Impact of Age on Stem Cell Function 6. Bone Marrow Mononuclear Cells 7. Chronic Limb Ischemia 8. Chronic/Refractory Angina 9. Acute Myocardial Infarction A. European Experience B. US Experience 10. Chronic Ischemic Heart Failure 11. Adipose Tissue 12. Overview of MSCs 13. Allogeneic vs Autologous Source: Comparative Effects 14. Use of MSCs for AMI 15. Combined Cell Strategies 16. Heart Failure 17. C-Kit+ cells 18. Cardiospheres 19. Umbilical Cord, Placenta, Endometrium 20. Genetic Engineering of Fibroblasts to Cardiomyocytes 21. Transformation to inducible Pleuripotent Stem Cells 22. Transformation to MAPC's 23. Transcoronary and Endocardial 24. Retrograde and Epicardial 25. Epicardial Patch 26. Matrix Scaffolds 27. Matrix plus cells 28. Biomaterial: Alginate 29. Organogenesis 30. Pre-clinical Identification of target genes 31. SERCA-2a gene for recovery of inotropic function 32. SDF-1 Gene for Heart Failure Non-Inotropic Mechanisms 33. Gene Therapy for Angiogenesis: Chronic Limb Ischemia 34. Stem Cells Target Gene Transfected Stem Cells 35. CCTRN: Past, Present, and Vision for the Future 36. Signature of Responders-lessons from Bio-Repository 37. Adjunctive therapy with LVADs for Recovery 38. Trials in Non-Ischemic Heart Failure 39. Enhancing Stem Cell Homing for Tissue Repair 40. Stroke: Pre-Clinical and Clinical Trial Data
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826